Abstract:OBJECTIVE:To discuss the methods and effects of a series of surgery oriented therapies in the treatment of large primary liver cancers.METHODS:From January 1993 to June 1999, 191 patients with large liver cancer were treated chiefly by operation. The size of the primary cancer varied from 5.2 to 19.7 cm (median 9.4 cm). Various kinds of liver resections were performed in 121 patients and, as a supplement, deep cryosurgery was carried for out the rest 70 patients. Importable drug delivery system (IDDS) was instituted intraoperatively. Transcatheter arterial chemo-embolization (TACE, THP 30-60 mg, E-ADM 20-40 mg, CDDP 40-80 mg, MMC 10-20 mg, iodine oil 5-30 ml), percutaneous ethanol injection (PEI), bioimmunotherapy and the traditional Chinese medicine were used pre- and post-operatively. CT angiography (CTA) and CT during arterial portography (CTAP) were used to find satellite nodules. Early recurrence was diagnosed by AFPmRNA monitor in peripheral blood. Child's classification plus branch chain amino acid/aromatic amino acid (BCAA/AAA) were adopted in evaluating the pre-operative liver functions.RESULTS:Remarkable results were observed after this surgery oriented serial treatment. The 1-, 3- and 5-year survival rates in the resection group were 75.8%, 45.6% and 30.4%, respectively. The 1- and 3-year survival rates in the cryosurgery group were 63.2% and 37.0%. The operative mortality was 1.6%. Recurrence rates were 69.2% in AFPmRNA positive group and 33.3% in AFPmRNA negative group. Comparing this two groups, significant difference was observed (P < 0.05). BCAA/AAA were lower than 1.5 in two patients died after resection.CONCLUSION:A serial treatment with surgery as the chief modality gives satisfactory results in large primary liver cancers. This regimen should be adhered to as a main strategy in dealing with large liver cancers. AFPmRNA in the peripheral blood, signifying a recurrence, may become a hope of a new clinical parameter. BCAA/AAA plus Child's classification is able to evaluate more accurately the hepatic functional reserve before surgery.

Surgical Treatment for Primary Liver Cancer

Surgical Treatment for Giant Primary Liver Cancer:A Report of 146 Cases

Retrospective Analysis on 682 Cases of Liver Cancer after Surgical Treatment

Surgical Treatment of Primary Liver Cancer: Report of 5524 Patients

Surgical Treatments of Primary Liver Cancer Patients with Severe Cirrhosis: a Report of 78 Cases CHEN

Surgical Treatment of Primary Hepatoeellular Carcinoma: a 20-Year Clinical Experience in 7566 Patients

A Surgery Oriented Serial Treatments of 191 Patients with Large Primary Liver Cancer

Surgical Treatment for Primary Liver Cancer with Portal Vein Tumor Thrombus(13 Cases Report)

Evaluation of Surgical Approach for Extrahepatic Cholangiocarcinoma.

Analysis of Survival Rate and Influencing Factors in Surgical Treatment of Primary Hepatocellular Carcinoma

Results of Liver Resection for Primary Liver Cancer

[Current approaches to surgical treatment of liver tumors]

Surgery for Primary Liver Cancer: A Forty Years Survey

[Surgery for Patients with Primary Liver Cancer: Report of 1,038 Patients].

Analysis of Surgery for Multiple Primary Cancers in Liver and Gastrium: a Report of 14 Cases

Hepatectomy Treating Primary Liver Cancer: 300 Cases Report

The Changing Role of Surgery in the Treatment of Primary Liver Cancer

Liver Resection and Surgical Strategies for Management of Primary Liver Cancer

Perioperative Management of Primary Liver Cancer

Serial Therapies Oriented by Surgery for Large Primary Liver Carcinoma.

Surgical treatment of liver malignant tumors with extrahepatic metastasis